o NoneEntity Type
0001498382
DelMar Pharmaceuticals, Inc.
Berry Only Inc.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Kintara Therapeutics, Inc.
Jurisdiction of Incorporation/OrganizationNEVADA 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 Kintara Therapeutics, Inc. 
Street Address 1Street Address 2
 12707 HIGH BLUFF DR., SUITE 200 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 SAN DIEGO CALIFORNIA 92130 858-350-4364 



3. Related Persons
Last NameFirst NameMiddle Name
ZarrabianSaiid
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
BrownDennis
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
PraillScott
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
LiatosJohn
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
HoffmanRobert
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
TothRobert
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
JohnsonLaura
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
MurphyKeith
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
RychnovskySteven
Street Address 1Street Address 2
12707 High Bluff Drive, Suite 200
CityState/Province/CountryZIP/Postal Code
San DiegoCALIFORNIA92130
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-08-19 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security x Other (describe)
 Series C Convertible Preferred Stock


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? x Yes o No
 
Clarification of Response (if Necessary) 
 Adgero Acquisition Corp., the Company's wholly-owned subsidiary merged with and into Adgero BioPharmaceuticals Holdings, Inc. ("Adgero"), with Adgero surviving the merger and becoming a wholly-owned direct subsidiary of the Company.

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 Aegis Capital Corp. 15007
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 810 7TH AVENUE 18TH FLOOR
City State/Province/CountryZIP/Postal Code
 NEW YORK NEW YORK 10019
State(s) of Solicitation x All States x Foreign/Non-US
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 30000000 USD o Indefinite
Total Amount Sold $ 21772000 USD 
Total Remaining to be Sold $ 8228000 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 161


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 3000000 USD x Estimate
Finders' Fees$ 0 USD x Estimate
 
Clarification of Response (if Necessary)
 Assumes maximum commissions earned and over-allotment option exercised. Excludes expenses and value of up to 3,000 warrants received as compensation.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD x
Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Kintara Therapeutics Charts.
Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Kintara Therapeutics Charts.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KTRA Message Board. Create One! See More Posts on KTRA Message Board See More Message Board Posts

Kintara Therapeutics, Inc. News

Loading Messages....

More Kintara Therapeutics, Inc. News Articles